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SUMMARY 
Objectives: Implantation of an Artificial Urethral Sphincter is a surgical treatment of urinary sphincter 
mechanism incontinence in dogs.  However, gauging optimal Artificial Urethral Sphincter inflation to 
restore continence without provoking dysuria is challenging. This preliminary study determines if 
Artificial Urethral Sphincter filling volume is proportional to peak pressure exerted on the urethra, 
and describes the relationship between Artificial Urethral Sphincter filling and pressure exerted.   
Methods: Urethral pressure profilometry was performed in five female, medium sized, mixed-breed 
canine cadavers following Artificial Urethral Sphincter placement.  Maximum urethral pressure was 
recorded following sequential incremental inflation of 0.15mL and compared to baseline pressure and 
between dogs using a two-way ANOVA.   
Results: Artificial Urethral Sphincter placement in cadavers was associated with an increase in 
urethral pressure and was significantly correlated with Artificial Urethral Sphincter volume. The 
correlation was non-linear and demonstrated significant individual variation. Maximum urethral 
pressures after Artificial Urethral Sphincter placement exceeded those reported of conscious continent 
dogs within a narrow volume range, where a 0.15mL infusion more than doubled  maximal urethral 
pressures. 
It is known that hydraulic Artificial Urethral Sphincter pressure is independent of muscle tone and 
cadavers may still demonstrate relevant clinical patterns of response. We conclude that rapid increases 
in urethral pressure from the Artificial Urethral Sphincter over a small range of filling volumes 
(0.15mL increments) might explain why some clinical cases can become suddenly dysuric following 
incremental Artificial Urethral Sphincter inflations. Further clinical studies are required, although we 
suggest that smaller increments of filling (0.05-0.1mL) may achieve finer pressure control.  
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INTRODUCTION  
Urinary incontinence may be defined as involuntary loss of urine during bladder filling (Reichler and 
Hubler, 2014).  Urethral Sphincter Mechanism Incompetence (USMI) is the most common cause of 
urinary incontinence in dogs (Holt, 1990a) with a prevalence of 20% in neutered bitches (Arnold et al. 
1989). Neutering is a confirmed risk factor (Holt and Thrusfield, 1993).  The pathophysiology of 
USMI in neutered dogs is incompletely understood, although a reduced urethral pressure is 
implicated. Significant reduction in urethral pressures have been recorded in incontinent compared to 
continent bitches (Arnold, 1997).  Salomon et al. (2006) reported that the mean urethral closing 
pressure significantly reduces post-spaying with a lag period of at least six months.  Structural 
urethral changes, including reduced smooth muscle mass and increased collagen content, have also 
been described (Noel et al., 2010).   
USMI is treated medically with α adrenergic agonist phenylpropanolamine and estriol with success 
varying from 75 to 95% (Mandigers and Nell, 2001, Bacon et al., 2002, Noel et al., 2010). Surgical 
treatments for USMI are usually pursued when medical treatment fails (Claeys et al., 2010a).  
Described techniques include colposuspension (Holt, 1990b), urethropexy (White, 2001, Martinoli et 
al., 2014), sphincter bulking (Byron et al., 2011), trans-obturator vaginal tape (Claeys et al., 2010b) 
and artificial urethral sphincters (AUS).  Colposuspension is the surgery most commonly performed 
for treatment of USMI, and its long-term outcome is successful in 53% cases (Holt, 1990b).    
The use of AUS for management of urinary incontinence in dogs by manipulating urethral pressure 
profiles was first reported in cadavers (Adin et al., 2004).  A significant increase in both urethral 
closing pressure and cystourethral leak point pressure was recorded at 50% occlusion compared to 
baseline.  Adin et al. (2004) measured ‘percentage occlusion’ of the AUS device ex vivo by 
measuring digital images of the AUS lumen at various increments of filling.  This was then correlated 
with urethral closing pressures achieved after AUS placement and inflation to the predetermined 
volumes of filling equivalent to 0%, 25% and 50% occlusion.  It is difficult, however, to interpret 
these results in a clinical situation when an AUS is already in situ and the level of functional urethral 
occlusion cannot easily be determined.  A more useful parameter would be the occluder filling 
volume correlated with pressure exerted on the urethra, which can be measured clinically by 
profilometry, as this may help to direct clinicians on AUS inflation after placement.   
Outcomes following AUS placement have been reported in prospective (Rose et al., 2009) and 
retrospective studies (Reeves et al., 2012, Delisser et al., 2012, Currao et al., 2013, Gomes et al., 
2018, Morgan et al., 2018).   Overall, AUS placement has a good outcome with up to 80% of cases 
reported as completely continent, without the need for additional medical treatment, 12 months post-
operatively (Gomez et al., 2018). Minor complications were seen in 30 to 81.8% of cases at varying 
periods post-operatively and resolved with either no or minimally invasive treatment. Major 
complications such as urethral obstruction requiring surgical intervention were recorded in 7 to 27% 
of cases and these were managed by AUS deflation or removal (Delisser et al., 2012, Reeves et al., 
2012, Currao et al., 2013, Gomes et al., 2018).  Port-dislodgement, and peri-AUS fibrosis requiring 
surgical correction have also been reported (Morgan et al., 2018). 
Study Aims 
AUSs are typically placed uninflated and repeated inflations of 0.1 to 0.5mL of saline are carried out 
on persistently incontinent dogs over prolonged follow-up periods (Delisser et al. 2012).   Clinical 
experience of using AUSs has shown that it can be challenging to manage persistent incontinence via 
sequential cuff inflation without inducing dysuria in dogs (Gomes et al., 2018).  The aim of this study 
was to perform a preliminary investigation to determine if the volume of AUS filling is proportional 
to the peak pressure exerted on the urethra, and investigate whether the relationship between AUS 
filling and pressure exerted is linear. In order to derive clinically useful data, small increments of 
infusion volume were used to reflect the range of volumes used clinically (0.1mL to 0.5mL). 
MATERIALS AND METHODS 
Cadavers 
5 female, medium sized (15-22kg), mixed breed (4 Staffordshire Bull Terrier crosses, 1 Collie cross) 
dogs were euthanised for reasons not related to this study.  Cadavers were obtained frozen and 
defrosted for 48 hours before testing took place.  A ventral midline coeliotomy was performed from 
umbilicus to the pubic brim, with the cadaver supported in dorsal recumbency.  The bladder was 
retracted cranio-ventrally to expose the urethra and vagina.  An episiotomy was performed and a 
urinary catheter was placed to identify the urethra.  The peri-vaginal fat was reflected cranially, and 
blunt dissection was performed around the proximal urethra approximately 2 cm caudal to the bladder 
neck.   This zone of dissection was extended sufficiently along the urethral axis that the full width of 
the AUS could be passed around the urethra without the cuff becoming pinched by tissues.  The 
circumference of the urethra at this site was measured in each cadaver using a piece of free tape and 
loosely placing it around the urethra.  The corresponding length was measured against a ruler.  A 
10mm (internal diameter) x14mm (width) AUS (DOCXS Biomedical Products, California, USA) was 
inflated maximally with Hartmann’s solution to displace any air, test for leakage and to unstick any 
areas of adhesion between the silicone leaves of the cuff.  The fluid was removed to leave just the 
priming volume before placement.  The uninflated AUS was placed around the proximal urethra and 
sutured in place with 4-0 Nylon.  A stab incision was made in the lateral body wall adjacent to the 
occluder, and the AUS connector tubing was tunnelled into the subcutaneous space lateral to the body 
wall where it was connected to an injection port  
Urethral pressure profilometry 
Urethral pressure profiles (UPP) were measured as previously described (Life-Tech, 2008, Goldstein 
and Westropp, 2005).  Briefly, a 7F double-lumen UPP catheter (Life-Tech, Vermont USA) was used 
to generate a urethral pressure profile whist being withdrawn from a start point in the bladder neck, 
into the urethra and past the site of the AUS.  An automated syringe driver (Alaris GH, CareFusion, 
Basingstoke, UK), connected to the UPP catheter under tension, was set up with a primed 10mL 
syringe discharging at a rate of 300mL/h to withdraw the UPP catheter at a constant rate of 0.5mm/s 
(Goldstein and Westropp, 2005).  The UPP catheter was attached to a 3-way tap and connected to a 
fluid infusion and to a pressure monitor (SurgiVet Advisor Vital Signs Monitor, Smiths Medical, 
Massachusetts USA) via a fluid column.  The pressure sensor was zeroed to atmospheric pressure at 
the level of the urethra.  The UPP catheter was inserted into the urethra, palpated and positioned with 
the pressure transducer cranial to the bladder neck, the approximate distance of the transducer from 
the cranial edge of the AUS was recorded.  The catheter was infused with isotonic fluids 
(Hartmann’s) at a rate of 2mL/min (Goldstein and Westropp, 2005).  In each cadaver, profilometry 
was performed before placement of the AUS, following placement of the AUS with a priming 
volume, and with incremental doses of 0.15mL reflecting a clinical approach to AUS inflation 
(Delisser et al., 2012).  Pressure readings were recorded at 10 second intervals as the catheter was 
withdrawn from the urethra; each interval represented a 5mm distance.  Maximal observed urethral 
pressures were recorded for each increment of occluder volume. Each volume was tested in triplicate.  
Separate occluders and UPP catheters were used in each cadaver, and UPP was recorded with the 
cadaver in dorsal recumbency.  
Statistics 
Statistics were carried out using GraphPad Prism 5. The effect of incremental inflation of the 
AUS by 0.15mL inflations was measured using a two-way ANOVA.  Changes in urethral pressure 
measured at each level of inflation were compared to the background urethral pressure with the AUS 
placed, but uninflated.  A P value of 0.05 was used to denote the significance level. Urethral pressure 
values achieved following AUS inflation were described as higher or lower than those pressures 
recorded in clinically normal dogs, as reported by Fischer et al. (2003). 
 
 
RESULTS 
The effect of AUS placement on UPP 
Urethral size at the site of AUS placement ranged from 15-25 mm (median 20 mm; Table 1).  Dogs 2, 
3 and 5 showed no change in urethral pressure after placement of an uninflated AUS. In dog 1, a 
reduction in urethral pressure from 15.7 to 11.3 cm H2O was detected after AUS placement, however 
this difference in pressure profile did not coincide with the position of the AUS.  Dog 4 demonstrated 
a doubling of urethral pressure from 13.3 before AUS placement to 27.0 cm H2O after placement of 
an uninflated AUS. This increase in urethral pressure was at the approximate position of the AUS, 
indicating that the uninflated AUS may be exerting pressure at this point.   
Effect of AUS inflation on maximal urethral pressure 
An increase in maximal urethral pressure (above background levels) was observed in each cadaver 
following incremental inflation of the AUS (P <0.0001) (Table 1). When represented graphically, the 
increase in maximal urethral pressure followed a sigmoid curve (Figure 1): (i) a first portion of the 
curve representing the infused volume needed to obtain a significant change in maximal urethral 
pressure above the uninflated pressure; (ii) an exponential rise in pressure with incremental inflation 
of liquid; (iii) a plateau phase.  
During the first phase of the inflation, the AUS significantly increases maximum urethral pressure 
above baseline when the cuff is uninflated, however the magnitude of this effect was variable between 
dogs: dog 1 required 0.9mL, dog 2 required 0.3mL, dog 3 required 0.6mL, dog 4 required 0.75mL and 
dog 5 required 0.6mL. 
The clinical implications of the pressure changes recorded are best understood when compared to 
normal urethral pressure; 146.5+/- 41.9 cm H2O (Fischer et al., 2003).  According to this data, the 
minimum urethral pressure in normal, conscious, continent dogs was 104.6 cm H2O.  This pressure 
could be achieved after AUS placement and incremental inflation in each cadaver (Figure 1), although 
the target volume of inflation varied between dogs.  From a clinical stand point, the variations 
observed were large because in some dogs, a 0.15mL infusion led to more than a doubling of the 
maximal urethral pressure: (i) in Dog 1 the maximum urethral pressure was 63.7 cm H2O at 0.9mL of 
filling and increased to 159.3 cm H2O when the AUS was filled to 1.05mL; (ii) in Dog 2 an increase 
in urethral pressure from 84.3 cm H2O to 187.7 cm H2O when the AUS was filled from 0.3mL to 
0.45mL; (iii) in Dog 3 the maximum urethral pressure at 0.75 mL of inflation was recorded as 62.0 
cm H2O and increased to 132.7 cm H2O after the addition of another 0.15mL to the AUS.  In other 
dogs, the relative change in pressure was smaller but did reach values above normal urethral pressure 
for a single 0.15mL increment: (i) in Dog 4 the maximum urethral pressure at 0.75 mL of inflation 
was 98.7 cm H2O, increasing to 193.3 cm H2O after another 0.15mL inflation to 0.9 mL; (ii) Dog 5, 
which demonstrated the smallest increase in urethral pressure to reach the normal range,  recorded a 
maximum urethral pressure of 56.0 cm H2O at 0.6mL of filling increasing to 108.3 cm H2O when the 
AUS was filled to 0.75mL.  Following incremental filling of the AUS, the urethral pressure profiles 
indicated that increases in pressure exerted on the urethra are localised to the section of the urethra 
surrounded by the AUS (data not shown).   
 
DISCUSSION 
While this is not the first study to assess the use of AUS in canine cadavers, no previous study has 
correlated incremental AUS inflation with the maximal pressure exerted on the urethra.  Normal 
urethral pressure in conscious, continent dogs has been reported as 146.5+/- 41.9 cm H2O (Fischer et 
al., 2003).  As shown by Adin et al. (2004), the urethral pressure observed in a cadaver model is much 
lower than seen in conscious dogs.  Despite this, the effect of hydraulic AUSs in the treatment of 
USMI is independent of muscle tone, and cadavers may still be used to demonstrate relevant patterns 
of response, even if the recorded pressures are not within physiologically normal limits (Adin et al., 
2004). Following this it was considered more acceptable, in the initial instance, to perform 
preliminary investigations using cadavers rather than resourcing to study live companion dogs.  
The results of this study demonstrate that the placement of an AUS around the proximal urethra is 
associated with incremental increases in urethral pressure capable of exceeding 300 cm H2O.  This is 
above normal resting urethral pressure (Fischer et al., 2003).  The relationship observed is, however, 
both non-linear and significantly variable between the cadavers.  This finding supports clinical 
observations that some USMI cases treated with AUSs will require greater cuff inflation volumes than 
others to reach continence, with some cases becoming continent following AUS placement without 
any additional inflation, while others necessitate repeated deflations or removal (Reeves et al., 2012, 
Delisser et al., 2012, Gomes et al., 2018, Morgan et al., 2018).  This significant patient variation in 
addition to the intensive follow up management and potential need to resolve complications makes the 
placement of AUS devices undesirable for most first opinion practices.  
The clinical relevance of a ‘significant increase’ in urethral pressure following inflation of the AUS 
from the uninflated position is questionable, as it does not necessarily represent an effect seen 
clinically.  Incontinence occurs when resting bladder pressure exceeds urethral pressure, therefore a 
resting urethral pressure exceeding bladder pressure is required to prevent urinary incontinence in the 
normal dog.  This pressure level (146.5+/- 41.9 cm H2O) would appear to be an appropriate 
therapeutic aim when inflating AUSs to treat USMI (assuming there is no underlying detrusor 
instability).  Thus, a better approach to answer the clinical question (of whether a specific AUS 
volume can be recommended for treatment of USMI) would be to identify the volume of AUS 
inflation required to generate a urethral pressure exceeding that of resting urethral pressure in normal 
dogs.  Figure 1 shows the correlation of AUS volume on maximal urethral pressure compared to the 
above stated range of ‘normal resting urethral pressures’ as described by Fischer et al. (2003).  In each 
cadaver, this urethral pressure was achieved by incremental AUS inflation.  This result indicates that 
AUS is an effective means to treat incontinence by focally and artificially restoring urethral pressure.  
In addition to achieving ‘normal urethral pressure’, the graphs also demonstrate that this pressure is 
exceeded over a small increase of AUS volumes.  An increase in urethral pressure of 74- 97 cm H2O 
could be achieved by a single incremental increase of 0.15mL in the cadavers to achieve a maximum 
pressure exceeding 100 cm H2O.  The pattern of a rapid increase in urethral pressure exerted by the 
AUS over a small range of filling volumes might explain why some clinical cases can become 
suddenly dysuric following incremental AUS inflations despite previous incontinence, and smaller 
increments of filling over this range of urethral pressures may achieve finer pressure control. 
There are many limitations to this study that restrict the drawing of any inferences regarding the 
clinical significance of AUS inflation volume on urethral pressure in live dogs.  Foremost, from a 
study size of five cadavers it is difficult to relate the results to a general population.  There is, 
arguably, limited value in comparing UPP recorded in cadavers to those recorded in conscious dogs as 
they are known to be significantly different (Adin et al., 2004).  In a conscious dog muscle tone, 
abdominal and pelvic pressures may influence UPP but cannot be assessed in a cadaver model.  
Despite this, correlations between AUS volume and maximal urethral pressure, and patterns of 
responses of individual dogs are still relevant, and are a useful preliminary investigation prior to 
conducting clinical studies.  In this study, all cadavers demonstrate a significant increase in urethral 
pressure from baseline (uninflated cuff in position) at 0.9mL.  Clinically, a mean volume of 0.4mL 
(0.1-0.7mL) is required to achieve maximal continence (Reeves et al., 2012).  This is a smaller 
volume than seen in this cadaver study, although 3/5 cadavers reached the normal urethral pressure 
range with 0.75mL inflation, and one dog responded adequately to an inflation of 0.3mL.  This 
difference in volume requirement between cadavers and clinical cases is most likely due to the 
artificially low basal urethral pressures in the cadavers.  It could be expected, therefore, that higher 
resting urethral pressures, even in an incontinent dog, will require a smaller pressure exerted by an 
AUS to achieve continence.  In addition, irritation and tissue disruption due to surgical placement of 
the AUS in clinical cases may induce a degree of muscular spasm in the early postoperative period 
whilst periurethral fibrosis may develop at a later stage (Morgan et al., 2018), also contributing to 
increasing urethral tone post-operatively.   
The magnitude of effect of AUS inflation was variable between cadavers.  In the present study, a 
standard sized (10x14mm) AUS was placed on each cadaver irrespective of urethral circumference 
(range 15-25mm).  AUS size selection in clinical cases has previously been based on approximate 
measurement of the circumference of the urethra and placement of an AUS with equal or larger 
circumference (Reeves et al., 2012).  Whereas Currao et al., (2012) reported a surgical technique 
whereby AUS luminal diameter size was calculated as 50% of the urethral circumference at the site of 
placement, however there is  no consensus for selection of, and little evidence to recommend specific 
AUS sizes in dogs.  The use of a single size of AUS on different sized urethras may account for some 
of the variation in the individual responses measured, although a larger sample size would be required 
to demonstrate the significance of matching AUS and urethral size.  In humans, there was no effect in 
short term incontinence following AUS placement with implants 4mm smaller or 4mm larger than the 
urethral circumference (Rothschild et al., 2014), suggesting that matching to exact urethral 
measurement may not be of clinical importance.  Use of the relatively larger cuff size was associated 
with improved long term outcome (Rothschild et al.,2014).  While Adin et al. (2004) showed no 
significant variation in inflation between different occluders, the use of a different AUS in each 
cadaver may contribute to some individual variation between cadavers.  This method was, however, 
deemed appropriate by the authors to reduce damage associated with repeated fixation and 
replacement, which might have altered AUS performance if the same device was used repeatedly.  
The study may have been improved by repeating the AUS placement and measurements of urethral 
pressures a further two more times on each cadaver to establish repeatability.  While a pattern has 
been observed in this dataset, it is not possible to confirm that the variability between dogs was due to 
difference in urethral size, or an intrinsic property of the AUS inflating around a soft tissue structure.  
Collection of these additional data was limited due to time and resources, and therefore the results 
remain preliminary. 
The effect of incremental AUS inflation on maximum urethral pressure was not linear.  The manner 
of placement of the AUS around the urethra means that the occlusive effect during inflation is not 
concentric; instead, the leaves of the AUS hinge asymmetrically.  Depending on the size or relative 
position of the urethra within the AUS, the shape of the AUS will differentially affect urethral 
pressure.    Adin et al., (2004) demonstrated strong correlation between percentage occlusion of the 
AUS when not positioned around the urethra and incremental AUS filling, as determined by using 
digital images to calculate the resultant luminal area.  The use of percentage occlusion ex-vivo is less 
useful clinically, as when the AUS is placed in situ, the "luminal area" can no longer be visualised and 
entrapped soft tissues will alter filling profiles.  When placed around the urethra of cadavers and the 
AUS inflated with pre-determined volumes corresponding to reach 25% and 50% occlusion, a non-
linear relationship between filling volume and mean cysto-urethral leak point pressure was observed; 
with significant difference from baseline cysto-urethral leak point pressure apparent at 50% occlusion 
(Adin et al., 2004).  The effect of incremental inflation on urethral pressure profilometry was not 
directly assessed. 
 It is beyond the scope of this study to determine whether a specific AUS volume can achieve 
continence in all cases of USMI, however, the present study provides preliminary evidence of a 
relationship between AUS volume and maximal urethral pressure.  To fully determine the clinical 
significance of such a correlation, a further study evaluating urethral profilometry in clinical cases 
undergoing AUS placement filling is required. We have been able to show that using small volume 
increments (0.15mL) is a valid approach and our preliminary data can be used as benchmark to design 
the next study in live companion dogs. In fact, it can now be considered that researching the effect of 
incremental filling with use of aliquots ranging from 0.05mL to 0.1mL should be done. The results of 
a clinical study would be able to direct clinicians as to whether incremental filling, use of urethral 
pressure profilometry, or use of clinical effect should be considered the recommended standard of 
care. 
CONCLUSION 
The placement of AUSs in cadavers was associated with a focal, non-linear increase in urethral 
pressure significantly correlated with AUS volume.  Although the correlation between maximal 
urethral pressure and AUS volume was significant in all cadavers, the magnitude of the response is 
different between individuals. This observation is also reflected in clinical experience of treating 
USMI with AUS placement.  These preliminary results suggest that incremental AUS inflation is 
suitable for the treatment of USMI, however further investigation of UPP in live companion animals 
undergoing AUS placement is indicated for interpretation of the true significance of this data. 
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FIGURES 
Figure 1: The line graphs (a) to (e) display the correlation between maximum recorded urethral 
pressure and incremental increases in AUS volume for each cadaver Dog 1 to 5 respectively.  Each of 
the three repeats for each recording is displayed along with a line joining the mean pressure recorded.  
The dotted line highlights the range of normal urethral pressures of 104.6-188.4 cm H2O  encountered 
in conscious, continent dogs (Fischer et al., 2003), which can be focally exceeded in cadavers by the 
pressure exerted by filling of the AUS.  * denotes a significant increase in maximal urethral pressure 
compared to an uninflated cuff; P<0.05. 
 
  
TABLES 
Table 1: This table displays, for each cadaver, the size of the urethra and the volumes of AUS 
inflation (after the priming volume) at which the urethral pressure change was increased significantly 
from that measured with an AUS placed, but uninflated.   P <0.05 was used as the significance level, 
* denotes P <0.01, † denotes  P <0.001 .  The corresponding t values for each inflation are displayed.  
In all cadavers, the maximum urethral pressure was recorded within the section of the urethra 
surrounded by the AUS. 
 
 
  
Figure 1. 

 
  
Table 1. 
Cadaver Urethral 
circumference (mm) 
AUS inflation volume  
generating significant 
urethral pressure change 
after placement (mL) 
t value  
Dog 1 15 0.9 *  
1.05 † 
6.091 
20.56 
Dog 2 20 0.15* 
0.3 † 
0.45 † 
0.6 † 
0.75 † 
0.9 † 
1.05 † 
3.712 
10.09 
24.84 
36.98 
40.88 
40.88 
40.88 
Dog 3 25 0.6 † 
0.75 † 
0.9 † 
1.05 † 
3.665 
6.045 
16.13 
29.56 
Dog 4 20 0.75 † 
0.9 † 
1.05† 
9.995 
23.51 
37.27 
Dog 5 25 0.6 * 
0.75 † 
0.9 † 
1.05 † 
6.140 
13.61 
24.27 
31.36 
 
 
